Skip to content
My WebMD Sign In, Sign Up

Alzheimer's Disease Health Center

Font Size

New Thinking About Alzheimer's Treatment

Current therapies are the triumph of hope over experience.

Plaque Attacks and Tangled Webs continued...

But whether beta amyloid and tau are the causes of Alzheimer's disease or a result of it is still unclear.

"Clearly, beta-amyloid and tau pathology are part of the disease. The question is at what point in the cascade of events these things come into the picture," Alzheimer's disease research pioneer Zaven Khatchaturian, PhD, tells WebMD.

Khatchaturian, who is a consultant to other Alzheimer's disease researchers, formerly headed the Office of Alzheimer's Disease Research at the National Institute on Aging. He says that while it's encouraging that anti-amyloid therapies have gotten over the first hump -- safety in humans -- it's still unclear whether these therapies will have a positive effect on the disease itself.

Khatchaturian says instead of attacking late-stage features of the disease, it might be possible to intervene at an earlier step, before the normal brain protein known as amyloid precursor protein (APP) is transformed into the abnormal form beta amyloid.

"[APP] is a very significant protein in cell-to-cell communication. It's been around since the fruit fly, and there are different versions of it, but we don't have any idea about its function. One target may be that we're looking at the wrong end of the story, that the real story might be before it gets broken," Khatchaturian says.

Could Stem Cells Stem the Tide of AD?

Although human embryonic stem cells show promise for many neurological diseases such as Parkinson's disease, Huntington's chorea, spinal cord injuries, and other conditions, the complexity of Alzheimer's disease and the difficulty of delivering stem cells to the regions of the brain that are affected make them impractical for widespread use.

"Stem cells, although they're promising for other diseases, it's not very likely practically that they'll be used for Alzheimer's disease, because the way stem cell replacement is practiced in clinical research is by surgically implanting stem cells into regions of the brain where there has been degeneration, and that's fairly local in terms of Parkinson's disease and Huntington's, but for the entire cerebral cortex you're talking about making dozens of little holes in the skull," says Sam Gandy, MD, PhD, director of the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia.

"There is a fairly new area focusing on identification of stem cells that are still present in the adult brain that weren't thought to be there," Gandy tells WebMD. "It's conceivable that if there were enough of those in quantity or you could deliver them, and if they have enough dividing potential you could stimulate them to replace the dying nerve cells in their immediate environment, but that still is very complicated."

The job would involve turning on dormant stem cells, getting them to change into the right kind of cell, and then getting them to move to the part of the brain where they're needed to repair damage, a series of tasks that are beyond our current capabilities, Gandy says.

Sheldon L. Goldberg, president and CEO of the Alzheimer's Association, tells WebMD that few or none of the 800 or so grant applications for research funding received by the association this year have been for stem cell research.

Today on WebMD

alzheimer's disease warning signs
Alzheimers Overview
Best Memory Boosting Games
mri scan of human brain
senior man
daughter and father
Making Diagnosis
Colored mri of brain
Close up of elderly couple holding hands
senior woman with lost expression
Woman comforting ailing mother
Alzheimers Dementia